U.S. Home Healthcare Market (By Component: Equipment, Service) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The U.S. home healthcare market size was estimated at around USD 142.93 billion in 2022 and it is projected to hit around USD 294.58 billion by 2032, growing at a CAGR of 7.5% from 2023 to 2032.

U.S. Home Healthcare Market Size 2023 to 2032

Key Pointers

  • The services segment held the largest market share in terms of revenue during 2022.
  • The skilled home healthcare services segment accounted for the largest share in terms of market revenue and is expected to register the fastest growth over the forecast period.
Report Coverage Details
Market Size in 2022 USD 142.93 billion
Revenue Forecast by 2032 USD 294.58 billion
Growth rate from 2023 to 2032 CAGR of 7.5%
Base Year 2022
Forecast Period 2023 to 2032
Companies Covered McKesson Medical-Surgical, Inc.; NxStage Medical (Fresenius Medical Care); Medline Industries Inc.; Medtronic plc; 3M Healthcare; Baxter International Inc.; B. Braun Melsungen AG; F. Hoffman-La Roche AG; Becton, Dickinson and Company; Kindred Healthcare, LLC; Brookdale Senior Living Inc.; Sunrise Senior Living, LLC; Genesis Healthcare, Inc.; Capital Senior Living Corporation (Sonida Senior Living); Diversicare Healthcare Services, Inc.; Senior Care Center; Atria Senior Living, Inc.; Amedisys, Inc.; Home Instead, Inc.

 

The Growing geriatric population and increasing prevalence of chronic diseases along with favorable reimbursement for home healthcare equipment are key drivers for the U.S. market. The recent advancements in technology & cost-effectivity of home healthcare services are likely to drive growth during the forecast period.

The U.S. geriatric population has been growing rapidly over the past decade. As per the U.S. Census Bureau, 54 million adults in the U.S. are aged 65 years & above, accounting for 16.5% of the country’s population. The geriatric population typically prefers to stay at home as they age instead of a medical facility. Moreover, older patients opt for home healthcare services following surgery or treatment at the hospital to reduce the hospital stay, resulting in higher demand for home healthcare services. Administration of medications at home for chronic disorders offers benefits, such as faster recovery, better experience, fewer complications, and reduced cost, which is boosting the demand for homecare services in the U.S.

Medicare provides reimbursement for home health services such as intermittent skilled nursing care, care provided by a home health aide, and therapy under either Part A or Part B, depending on the circumstances. However, government organizations are taking measures to get service providers to focus more on the clinical characteristics of the patients, to eliminate the use of therapy service thresholds. For instance, a major change to the reimbursement system in decades is the Patient-Driven Groupings Model (PDGM) that was implemented in January 2020, which is reshaping the reimbursement of home healthcare services.

The initial phase of the pandemic witnessed complete shutdowns and movement restrictions leading to a shortage of medical equipment for use at homes as well as hospitals. Restrictions on healthcare services and fear of COVID-19 infection resulted in increased adoption of home health services across the nation, as it helped treat patients with professional support at home itself, avoiding the risk of infection. Healthcare facilities are providing care programs such as hospital-at-home and SNF-at-home that is reducing the stress on facilities and saving healthcare expenditure for patients. 

The concept of home healthcare has evolved over the years and is likely to play an integral role in future healthcare systems in the U.S. Over the past few years, there have been rapid advancements in technologies used by home healthcare providers. Electronic visit verification is an upcoming technology, that facilitates verification of caregiver appointments, scheduling, & cancellation, avoiding no-show home appointments. The verification includes information about the patient and home healthcare professional, including the location, date, and time of service required. According to the social services department, by 2023, all home healthcare service providers in the U.S. must implement electronic visit verification, as per recent regulations.

U.S. Home Healthcare Market Segmentations:

By Component

  • Equipment
    • Therapeutic Equipment
      • Home respiratory equipment
      • Home IV pumps
      • Home dialysis equipment
      • Insulin delivery
      • Other therapeutic equipment
    • Diagnostic Equipment
      • Diabetic care unit
      • BP monitors
      • Multi para diagnostic monitors
      • Apnea and sleep monitors
      • Home pregnancy and fertility kits
      • Holter monitors
      • Heart rate meters
      • Other diagnostic equipment
    • Mobility Assist Equipment
      • Wheelchair
      • Home medical furniture
      • Walking assist devices
  • Service
    • Skilled Home Healthcare Services
      • Nursing care
      • Physician/primary care
      • Hospice & palliative care
      • Physical/occupational/speech therapy
      • Nutritional support
      • Other skilled home healthcare services
    • Unskilled Home Healthcare Services

Frequently Asked Questions

The U.S. home healthcare market size was reached at USD 142.93 billion in 2022 and it is projected to hit around USD 294.58 billion by 2032.

The U.S. home healthcare market is growing at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2032.

Key factors that are driving the U.S. home healthcare market growth include rising need for solutions to reduce healthcare costs, increasing focus on patient-centric care, and strong government support.

Chapter 1. Introduction

1.1.Research Objective                     

1.2.Scope of the Study

1.3.Definition

Chapter 2. Research Methodology

2.1.Research Approach

2.2.Data Sources

2.3.Assumptions & Limitations

Chapter 3. Executive Summary

3.1.Market Snapshot

Chapter 4. Market Variables and Scope

4.1.Introduction

4.2.Market Classification and Scope

4.3.Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5.COVID 19 Impact on U.S. Home Healthcare Market

5.1. COVID-19 Landscape: U.S. Home Healthcare Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4.Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1.Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2.Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1.List of Suppliers

7.1.3.2.List of Buyers

Chapter 8. U.S. Home Healthcare Market, By Component

8.1.U.S. Home Healthcare Market, by Component Type, 2023-2032

8.1.1. Equipment

8.1.1.1.Market Revenue and Forecast (2019-2032)

8.1.2. Service

8.1.2.1.Market Revenue and Forecast (2019-2032)

Chapter 9. U.S. Home Healthcare Market, Regional Estimates and Trend Forecast

9.1. U.S.

9.1.1. Market Revenue and Forecast, by Component (2019-2032)

Chapter 10.Company Profiles

10.1. McKesson Medical-Surgical, Inc.

10.1.1.Company Overview

10.1.2.Product Offerings

10.1.3.Financial Performance

10.1.4.Recent Initiatives

10.2. NxStage Medical (Fresenius Medical Care)

10.2.1.Company Overview

10.2.2.Product Offerings

10.2.3.Financial Performance

10.2.4.Recent Initiatives

10.3. Medline Industries Inc.

10.3.1.Company Overview

10.3.2.Product Offerings

10.3.3.Financial Performance

10.3.4.Recent Initiatives

10.4. Medtronic plc

10.4.1.Company Overview

10.4.2.Product Offerings

10.4.3.Financial Performance

10.4.4.Recent Initiatives

10.5. 3M Healthcare

10.5.1.Company Overview

10.5.2.Product Offerings

10.5.3.Financial Performance

10.5.4.Recent Initiatives

10.6. Baxter International Inc.

10.6.1.Company Overview

10.6.2.Product Offerings

10.6.3.Financial Performance

10.6.4.Recent Initiatives

10.7. B. Braun Melsungen AG

10.7.1.Company Overview

10.7.2.Product Offerings

10.7.3.Financial Performance

10.7.4.Recent Initiatives

10.8. F. Hoffman-La Roche AG

10.8.1.Company Overview

10.8.2.Product Offerings

10.8.3.Financial Performance

10.8.4.Recent Initiatives

10.9. Becton

10.9.1.Company Overview

10.9.2.Product Offerings

10.9.3.Financial Performance

10.9.4.Recent Initiatives

10.10. Dickinson and Company

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11.Research Methodology

11.1.Primary Research

11.2.Secondary Research

11.3.Assumptions

Chapter 12.Appendix

12.1. About Us

12.2. Glossary of Terms

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers